← Back to Search

Risk Score

Risk Reduction Intervention for Iatrogenic Disease (AGING Trial)

N/A

Recruiting

Research Sponsored by Rutgers, The State University of New Jersey

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Baseline medication risk score of 20 or more

Hospital admission for at least 48 hours

Must not have

Discharge to hospice

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at time of intervention

Awards & highlights

No Placebo-Only Group

Summary

This trial will test whether the MedWise Risk Score can help identify which patients are at high risk for readmission and target them for interventions.

Who is the study for?

This trial is for older adults who were in the hospital for at least 2 days, have a high medication risk score (20+), and are taking 5 or more medications upon leaving the hospital. It's not for those who left the hospital against advice, passed away during their stay, live far from the facility, or went to hospice care.

What is being tested?

The study tests if using MedWise Risk Score™ to guide treatment can lower this score and reduce chances of being readmitted within 30 days after discharge. High-risk patients will receive special attention to adjust their meds.

What are the potential side effects?

Since this intervention involves adjusting existing medications rather than testing new ones, side effects will vary based on changes made to each patient's medication regimen.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My medication risk score is 20 or higher.

Select...

I have been admitted to the hospital for at least 48 hours.

Select...

I was prescribed 5 or more medications when I left the hospital.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am being discharged to hospice care.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30 days after hospital discharge

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30 days after hospital discharge

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days after hospital discharge for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Number of individuals with an emergency department visit or hospital readmission

Secondary study objectives

Difference in score between patients aged older and younger than 65 years

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Discharge medication regimen instructions will be provided upon discharge after being assessed using the MWRS, optimized, and assessed by the prescriber.

Group II: Standard of CareActive Control1 Intervention

Discharge medication regimen instructions will be provided upon discharge after being assessed by the prescriber.

0 / 4Eligibility criteria met